Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
APRE
CNSP
Add up to 3 more stocks
APRE
Aprea Therapeutics, Inc.
-5.94%
$0.64-0.04Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$7.87M
52W Range
$0.55 - $1.69
CNSP
CNS Pharmaceuticals, Inc.
+0.03%
$5.30+0.00Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$7.75M
52W Range
$1.90 - $10.59
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.20 | 0.43 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -32.0% | -91.8% |
| ROA | -29.1% | -76.1% |
| ROIC | -33.7% | -92.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 13.55 | 5.86 |
| Quick Ratio | 13.55 | 5.86 |
| Debt/Equity | 0.00 | 0.00 |
| Interest Coverage | N/A | -1049.68 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.